Skip to main content

Table 4 Numerical values of the patients with adequate and inadequate rate control through diltiazem by genotypes

From: Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response

Genetic polymorphism

Adequate rate control with diltiazem

Inadequate rate control with diltiazem (%)

Total (%)

*1/*2

8 (%100.0)

1st dose (0.25 mg/kg): 8

2nd dose (0.35 mg/kg): 0

0 (0.0)

8 (100.0)

*1/*3

11 (%68.8)

1st dose (0.25 mg/kg): 6

2nd dose (0.35 mg/kg): 5

5 (31.2)

16 (100.0)

*1/*4

3 (%42.9)

1st dose (0.25 mg/kg): 0

2nd dose (0.35 mg/kg): 3

4 (57.1)

7 (100.0)

*2/*3

2 (%66.7)

1st dose (0.25 mg/kg): 0

2nd dose (0.35 mg/kg): 2

1 (33.3)

3 (100.0)

*2/*4

2 (%18,2)

1st dose (0.25 mg/kg): 0

2nd dose (0.35 mg/kg): 2

9 (81.8)

11 (100.0)

*3/*4

0 (%0.0)

7 (100.0)

7 (100.0)

*2/*10

0 (%0.0)

9 (100.0)

9 (100.0)

Total

26 (%42.6)

35 (57.4)

61 (100.0)